Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
Work
Year: 2021
Type: article
Source: The Lancet Oncology
Institutions Philipps University of Marburg, German Breast group, Universitätsklinikum Gießen und Marburg, National Center for Tumor Diseases, German Cancer Research Center +31 more
Cites: 28
Cited by: 377
Related to: 10
FWCI: 36.84
Citation percentile (by year/subfield): 100
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed
Funder Deutsche Krebshilfe
Grant ID 70113450